Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities.
Level 5 - mechanism / opinion, no new human data
Narrative review describing biochemical mechanisms and structural transitions without original human or clinical data.
PubMed 36158829 · doi:10.3389/fcvm.2022.979461
What was done
This narrative review synthesized biochemical and structural evidence describing how C-reactive protein interacts with cell membranes, lipoproteins including very low-density lipoprotein and low-density lipoprotein, apolipoprotein B, and cholesterol. The authors detailed the conformational steps through which the circulating pentameric isoform dissociates into the modified monomeric isoform.
What was found
The abstract reports no numerical findings, effect sizes, or statistical metrics. It describes a qualitative four-step activation mechanism: soluble pentameric C-reactive protein binds to membrane ligands like phosphocholine; binding forces induce structural relaxation into a membrane-bound intermediate; irreversible dissociation produces monomeric C-reactive protein, exposing a core cholesterol- and multi-ligand-binding site; and reduction of the subunit intrachain disulfide bond enhances ligand accessibility and initiates pro-inflammatory responses.
Why it matters
This structural model distinguishes inert circulating pentameric C-reactive protein from its active monomeric isoform. It explains how C-reactive protein can function directly as a mediator of inflammatory pathways rather than solely as a passive circulating biomarker.
Limits
The abstract describes a narrative mechanistic review rather than a systematic synthesis or an empirical clinical study. It includes no human participant data, quantitative binding kinetics, sample sizes, or evaluations of clinical outcomes.
Cited by
- context Very-low-density lipoproteins (VLDL) transport inflammatory proteins such as cytokines and C-reactive protein.